Carotid Stenting
- 1 February 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 45 (2), 527-532
- https://doi.org/10.1161/strokeaha.113.003526
Abstract
Background and Purpose— Randomized clinical trials show higher 30-day risk of stroke or death after carotid artery stenting compared with surgery. We examined whether operator experience is associated with 30-day risk of stroke or death in the Carotid Stenting Trialists’ Collaboration database. Methods— The Carotid Stenting Trialists’ Collaboration is a pooled individual patient database including all patients recruited in 3 randomized trials of stenting versus endarterectomy for symptomatic carotid stenosis (Endarterectomy Versus Angioplasty in patients with Symptomatic Severe Carotid Stenosis trial, Stent-Protected Angioplasty versus Carotid Endarterectomy trial, and International Carotid Stenting Study). Lifetime carotid artery stenting experience, lifetime experience in stenting procedures excluding the carotid, and annual number of procedures performed within the trial (in-trial volume), divided into tertiles, were used to measure operator experience. The outcome event was the occurrence of any stroke or death within 30 days of the procedure. The analysis was done per protocol. Results— Among 1546 patients who underwent carotid artery stenting, 120 (7.8%) had a stroke or death within 30 days of the procedure. The 30-day risk of stroke or death did not differ according to operator lifetime carotid artery stenting experience (P=0.8) or operator lifetime stenting experience excluding the carotid (P=0.7). In contrast, the 30-day risk of stroke or death was significantly higher in patients treated by operators with low (mean ≤3.2 procedures/y; risk 10.1%; adjusted risk ratio=2.30 [1.36–3.87]) and intermediate annual in-trial volumes (3.2–5.6 procedures/y; 8.4%; adjusted risk ratio=1.93 [1.14–3.27]) compared with patients treated by high annual in-trial volume operators (>5.6 procedures/y; 5.1%). Conclusions— Carotid stenting should only be performed by operators with annual procedure volume ≥6 cases per year.This publication has 20 references indexed in Scilit:
- Operator Experience and Carotid Stenting Outcomes in Medicare BeneficiariesJAMA, 2011
- Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)The Lancet Neurology, 2011
- Influence of Site and Operator Characteristics on Carotid Artery Stent Outcomes: Analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) Clinical StudyJACC: Cardiovascular Interventions, 2011
- The Carotid Revascularization Endarterectomy versus Stenting Trial: Credentialing of Interventionalists and Final Results of Lead-in PhaseJournal of Stroke and Cerebrovascular Diseases, 2010
- Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trialThe Lancet, 2010
- Systematic Review of the Perioperative Risks of Stroke or Death After Carotid Angioplasty and StentingStroke, 2009
- Conventional models overestimate the statistical significance of volume–outcome associations, compared with multilevel modelsJournal of Clinical Epidemiology, 2005
- Clinical competence statement on carotid stenting: Training and credentialing for carotid stenting—multispecialty consensus recommendations: A report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventionsJournal of the American College of Cardiology, 2005
- The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy TrialCerebrovascular Diseases, 2004
- Carotid Angioplasty and Stenting With and Without Cerebral ProtectionStroke, 2004